The Hidden Driver: Understanding Aldosterone’s Role in Persistent Uncontrolled Hypertension - CME - Guideline Central

CME

Title
The Hidden Driver: Understanding Aldosterone’s Role in Persistent Uncontrolled Hypertension
Link
Description
Learners will gain a clear understanding of key concepts, including the physiological role of aldosterone within the renin–angiotensin–aldosterone system, mechanisms of aldosterone dysregulation across a clinical continuum, the downstream effects of aldosterone dysregulation on vascular stiffness, inflammation, and fibrosis, and how excess aldosterone contributes to hypertension and organ damage.
Target Audience
Primary care healthcare practitioners, including general practitioners, nurses, and pharmacists in the United States, Europe (France, Germany, Italy, and Spain), Japan, China, Brazil, and the Gulf states (Saudi Arabia and the United Arab Emirates
Learning Objectives
  • Explain the physiological role of aldosterone and how dysregulation occurs along a continuum
  • Describe how excess aldosterone contributes to vascular stiffness, inflammation, and fibrosis
  • Identify how aldosterone-driven mechanisms relate to persistent uncontrolled hypertension and associated cardiorenal comorbidities
Estimated Duration
15 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Cardiology, Primary Care
Keywords
cardiovascular disease, Aldosterone, Uncontrolled Hypertension
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • Nexus Healthcare Education
  • Partners for Advancing Clinical Education
Commercial Support
  • AstraZeneca Pharmaceuticals
Activity Expiration Date
May 14, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.25 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.